NCT01287390已完成2 期
Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective Neck: a Multicenter, Two-arm, Randomized Phase II Trial.
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 4
- 主要终点
- Reduction of acute and late treatment-induced dysphagia
研究概览
简要总结
Severe acute and late dysphagia is now considered as a dose-limiting toxicity of radio(chemo)therapy for head and neck cancer that significantly affects patients' quality of life. We propose to preserve swallowing function by:
- adapting (individualizing) treatment (intensity-modulated radiotherapy: IMRT) to per-treatment changes occurring in the tumor and surrounding organs and tissues;
- reducing the volumes of elective neck, that may result in significant decrease of severe acute and late dysphagia.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologically confirmed squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx and larynx.
- •Primary non-resected tumor and/or patients refused surgery
- •Stage T1-4, N0-3; for cancer of the glottis T3-4 or T any N1-3
- •Decision of curative radiotherapy or radiochemotherapy made by a Multidisciplinary Group of Head and Neck Tumors at UZ Gent and UZ Gasthuisberg Leuven
- •Karnofsky performance status >= 70 %
- •Age >= 18 years old
- •Informed consent obtained, signed and dated before specific protocol procedures
排除标准
- •Treatment combined with brachytherapy
- •Prior irradiation to the head and neck region
- •Surgery of the primary tumor except lymph node dissection prior to radiotherapy
- •induction chemotherapy
- •history of prior malignancies, except for cured non-melanoma skin cancer, curatively treated in-situ carcinoma of the cervix or other cancer curatively treated and with no evidence of disease at least 5 years
- •Distant metastases
- •Creatinine clearance (Cockroft-Gault) =< 60 milliliter/minute before treatment or creatinine value > 1,3 milligram/deciliter
- •Known allergy to the CT-contrast agents
- •Pregnant or lactating women
- •Mental condition rendering the patient unable to understand the nature, scope and possible consequences of the study
- •Patient unlikely to comply with protocol, i.e. uncooperative attitude, inability to return for follow-up visits and unlikely to complete the study
结局指标
主要结局
Reduction of acute and late treatment-induced dysphagia
时间窗: after 1 year
Reduction of the rates of acute and late treatment-induced dysphagia with experimental treatment as compared to standard treatment.
次要结局
- acute treatment-induced toxicity(weekly during treatment)
- local, regional and distant control: imaging(after 3 months)
- local, regional and distant control: biopsy(from 3 months on)
- local, regional and distant control: clinical examination(after 1,3, 6, 9 and 12 months)
- late treatment-induced toxicity(after 1, 3, 6, 9 and 12 months)
- tumor response: imaging(after 3 months)
- tumor response: clinical examination(after 1, 3, 6, 9 and 12 months)
研究者
研究点 (4)
Loading locations...
相似试验
已完成
不适用
Prediction of Esophageal and Lung Toxicities After Radiation (Chemo) TherapyLung CancerNCT04545658University Hospital, Brest167
Unknown
不适用
Clinical Study Assessing the Effect of ZIVEREL® in Cancer PatientsAcute EsophagitisNCT04070677Grupo de Investigación Clínica en Oncología Radioterapia200
已完成
Unknown
Acoustic analysis of cough in head and neck cancer patients with swallowing disordersDysphagia and aspiration riskSigns and SymptomsISRCTN16540497Institut Jules Bordet71
已完成
不适用
PRO-ACTIVE: Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck CancerDysphagiaNCT03455608University Health Network, Toronto952
招募中
不适用
Image-guided Focal Dose Escalation- Primary pc Treated With Primary External Beam Hypofract.Stereotactic rtProstate CancerNCT06330909University Hospital Freiburg374